# ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units

- Link: https://www.thailand-business-news.com/pr-news/zeiss-medical-technology-and-aier-eye-hospital-group-sign-strategic-agreement-for-25-visumax-800-units
- Published: 2026-06-18T07:49:00+07:00
- Author: PR Newswire

|   |

JENA, Germany, June 18, 2026 /PRNewswire/ — ZEISS Medical Technology announced today
that the company held a signing ceremony with the Aier Eye Hospital Group, entering
into a strategic agreement for the purchase and installation of 25 ZEISS VISUMAX
800 femtosecond lasers across multiple Aier Eye Hospital locations. The signing 
ceremony was conducted on June 12 at the headquarters of Aier Eye Hospital Group
in Changsha, Hunan Province.

 [⌊ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units.⌉](https://mmx.prnasia.com/media/MS1868620/Signing_for_25_units_of_VISUMAX_800-1.jpg?id=OA2722099&p=medium600)

ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for
25 VISUMAX 800 Units.

The 25 ZEISS VISUMAX 800 systems covered by this agreement will be progressively
deployed across Aier Eye Hospital’s domestic and international networks starting
later in 2026. The strategic partnership between ZEISS Medical Technology and Aier
Eye Hospital Group aims to enhance high-quality patient care through technological
innovation, helping to bring precise and well proven refractive surgery to patients
worldwide.

"Aier Eye Hospital is one of ZEISS Medical Technology’s most important global strategic
partners. In the future, the two parties will explore deeper collaborative innovation
in areas such as international expansion, integrated digital workflows and platforms,
and AI-assisted diagnosis," said Martin Fischer, President & CEO of ZEISS Greater
China.

"Our collaboration with ZEISS has long transcended mere equipment procurement. We
are jointly exploring comprehensive synergies spanning from clinical management 
to digital applications. The introduction of 25 ZEISS VISUMAX 800 systems will help
Aier further enhance surgical efficiency and patient satisfaction, aiming to set
a new quality benchmark for refractive surgery worldwide," said Mr. Li LI, Co-Founder
and Global President of Aier Eye Hospital Group.

**Supporting a global patient care strategy**

At the signing ceremony, ZEISS Medical Technology presented Aier Eye Hospital Group
with a "Top Three" honorary plaque, acknowledging Aier’s global leadership across
three dimensions—equipment scale, talent pool, and clinical practice— further deepening
its strategic partnership with ZEISS Medical Technology, including:

 1. **Most ZEISS VISUMAX 800 Units Installed Globally:** Aier Eye Hospital will be 
    the ophthalmic institution with the largest installed base of ZEISS VISUMAX 800
    systems worldwide;
 2. **Most ZEISS SMILE pro-Certified Surgeons Globally:** Aier Eye Hospital boasts 
    the largest number of ZEISS SMILE pro-certified surgeons globally, demonstrating
    its strong advantages in technical training and talent development;
 3. **Highest Number of Procedures with ZEISS SMILE pro in China:** Aier Eye Hospital
    ranks first nationwide in the total number of KLEx procedures performed with ZEISS
    SMILE pro in China, maintaining a well-established position in clinical experience
    and patient satisfaction.

_Not all products, services or offers are approved or offered in every market and
approved labeling and instructions may vary from one country to another. For country-
specific product information, see the appropriate country website. Product specifications
are subject to change in design and scope of delivery as a result of ongoing technical
development. The statements of the healthcare professionals reflect only their personal
opinions and experiences and do not necessarily reflect the opinion of any institution
that they are affiliated with. The healthcare professionals alone are responsible
for the content of their experience reported and any potential resulting infringements.
Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting
the opinions and statements of the health care professionals nor accept any responsibility
or liability of the healthcare professionals’ content._ _The healthcare professionals
have a contractual or other financial relationship with Carl Zeiss Meditec AG and
its affiliates and have received financial support._

**Company Profile**

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX
of the German stock exchange, is one of the world’s leading medical technology companies.
The Company supplies innovative technologies and application-oriented solutions 
designed to help doctors improve the quality of life of their patients. The Company
offers complete solutions, including implants and consumables, to diagnose and treat
eye diseases. The Company creates innovative visualization solutions in the field
of microsurgery. With 5,784 employees worldwide, the Group generated revenue of 
€2,228m in fiscal year 2024/25 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in 
Germany and abroad; more than 50 percent of its employees are based in the USA, 
Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore,
India and the Carl Zeiss Innovations Center for Research and Development in Shanghai,
China, strengthen the Company’s presence in these rapidly developing economies. 
Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59
percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical
and optoelectronic industries.

For further information visit: [www.zeiss.com/med](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4713686-1&h=39968071&u=https%3A%2F%2Fwww.zeiss.com%2Fmed&a=www.zeiss.com%2Fmed)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units ](http://www.prnasia.com/story/archive/4985992_AE85992_0?rand=184833)
